Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Dental implant gum disease: new study tests gentler cleaning method

NCT ID NCT05899933

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two surgical treatments for peri-implantitis, a gum infection around dental implants. One method reshapes the implant surface (implantoplasty), while the other uses an erythritol air-abrasive device to clean it. Researchers will check which approach works better at reducing pocket depth, bleeding, and bacteria over one year. The trial involves 45 adults with at least one infected implant.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
erythritol air-abrasive device
What this could lead to
If successful, this could show that a less invasive cleaning method works as well as reshaping the implant, offering a simpler treatment option for peri-implantitis.
What could go wrong
This is a small, early-stage trial with only 45 participants, so results may not apply to everyone. Both procedures are surgical and carry risks like infection or implant failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: General Inclusion Criteria: * Participants ≥ 18 years and ≤ 80 years of age * Non-smokers based on the patients' self-reported smoking status, defined as patients who had never smoked or had quit smoking at least 2 years ago * Implants in function for more than 1 year after suprastructure connection Inclusion Criteria for implants diagnosed with Peri-Implantitis: * Presence of at least one implant diagnosed with peri-implantitis defined as presence of bleeding on probing and/or suppuration, probing pocket depth ≥6 mm and ≥3 mm of detectable bone loss after initial re-modelling * Absence of implant mobility * in participants with more than one implant, the implant with the worst clinical condition will be studied. Inclusion Criteria for implants diagnosed with Peri-Implant Health: * Absence of peri-implant signs of inflammation (redness, swelling) * Lack of bleeding on probing * Absence of bone loss beyond crestal bone level changes resulting from initial remodeling, which should not be ≥2 mm Exclusion Criteria: * Smokers * Uncontrolled diabetes mellitus (HBA1c \>7) * Treatment with bisphosphonates * Needing antibiotic prophylaxis * Currently pregnant or breast-feeding women * History of systemic administration of antibiotic treatment during the preceding 3 months * Systemic conditions that contraindicate treatment * Use of medications known to induce gingival hyperplasia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peri-implant health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Peri-Implantitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Periodontology, School of Dentistry, National and Kapodistrian University of Athens

    RECRUITING

    Athens, 11527, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.